Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Industry News
Genentech Focuses on Cancer as it Launches Biooncology Initiative
May 26th, 1997
Genentech, Inc., South San Francisco, California announced its entry into the oncology market with a new BioOncology initiative backed by a pipeline of innovative biotherapeutic agents. "With one drug being marketed and four products in development, Genentech has one of the strongest oncology pipelines in cancer research," said Arthur D. Levinson, Ph.D., Genentech's president and chief executive officer. "Recognizing our positive R&D results in this area and the significant commercial opportunity that these products represent, Genentech is committed to continuing its scientific and clinical efforts in the field of oncology." Genentech will enter the...
Source: Cancer Weekly (1997-05-26)
|
